New Delhi -°C
Today in New Delhi, India

Aug 12, 2020-Wednesday
-°C

Humidity
-

Wind
-

Select Country
Select city
ADVERTISEMENT
Home / India News / Zydus begins human trials for potential Covid-19 vaccine

Zydus begins human trials for potential Covid-19 vaccine

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated.

india Updated: Jul 15, 2020 10:12 IST
hindustantimes.com | Posted by: Shankhyaneel Sarkar
hindustantimes.com | Posted by: Shankhyaneel Sarkar
Bengaluru
injecting injection vaccine vaccination medicine flu man doctor insulin health drug influenza concept - stock image
injecting injection vaccine vaccination medicine flu man doctor insulin health drug influenza concept - stock image(HT Archive)

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Sign In to continue reading